Mitra opens U.S. branch to focus on cardiology nicheCanadian PACS software developer Mitra Imaging has launched a U.S. company to develop cardiology image and information management products. The new company, based in Hartland, WI, will promote
Canadian PACS software developer Mitra Imaging has launched a U.S. company to develop cardiology image and information management products. The new company, based in Hartland, WI, will promote and adapt Mitra's PACS Broker connectivity product for cardiology environments.
Waterloo, Ontario-based Mitra chose to base the U.S. company in Hartland due to its close proximity to area universities as well as several cardiology vendors, such as Camtronics Medical Systems, GE Medical Systems, and Marquette Medical Systems.
The U.S. company will join another Mitra subsidiary, Mitra ApS of Copenhagen, Denmark, which was launched in July.
Mitra also has received Food and Drug Administration 510(k) clearance for Image Vault, a Windows NT-based archiving software offering. Targeted primarily at cardiology, the DICOM-compliant Image Vault stores images on standard magnetic tapes, and has the ability to send, receive, display, store, and archive DICOM non-compressed and JPEG-compressed images. Image Vault, which is scalable, can also read/write a collection of images to and from CD-R media in a method defined by DICOM, according to the firm.
Image Vault is not the first archive offering developed by Mitra. The company developed a Unix-based product for radiology in an exclusive relationship with Agfa. That exclusive agreement applies only to radiology archiving, however, and Mitra anticipates that multiple firms will be accessing Image Vault in the cardiology realm, said Eric Peterson, president.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.